Should all patients receive statins to reduce cancer risk after heart transplantation?
Affiliation
Christie Hospital, Manchester, United KingdomIssue Date
2012-07-24
Metadata
Show full item recordCitation
Should all patients receive statins to reduce cancer risk after heart transplantation? 2012, 126 (4):391 CirculationJournal
CirculationDOI
10.1161/CIRCULATIONAHA.112.121343PubMed ID
22761454Type
ArticleLanguage
enISSN
1524-4539ae974a485f413a2113503eed53cd6c53
10.1161/CIRCULATIONAHA.112.121343
Scopus Count
Collections
Related articles
- Letter by Azoulay and Suissa regarding article, "statins and the risk of cancer after heart transplantation".
- Authors: Azoulay L, Suissa S
- Issue date: 2013 Feb 5
- Letter by Schmedt and Garbe regarding article, "statins and the risk of cancer after heart transplantation".
- Authors: Schmedt N, Garbe E
- Issue date: 2013 Feb 5
- Letter by Vorlat et al regarding article, "statins and the risk of cancer after heart transplantation".
- Authors: Vorlat A, Vermeulen T, Conraads V
- Issue date: 2013 Feb 5
- Response to letters regarding article, “statins and the risk of cancer after heart transplantation”.
- Authors: Fröhlich GM, Enseleit F, Wolfrum M, von Babo M, Frank M, Berli R, Hermann M, Holzmeister J, Noll G, Lüscher TF, Ruschitzka F, Rufibach K, Wilhelm M, Falk V
- Issue date: 2013 Feb 5
- Statins and the risk of cancer after heart transplantation.
- Authors: Fröhlich GM, Rufibach K, Enseleit F, Wolfrum M, von Babo M, Frank M, Berli R, Hermann M, Holzmeister J, Wilhelm M, Falk V, Noll G, Lüscher TF, Ruschitzka F
- Issue date: 2012 Jul 24